Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids.
Israa A SeliemSiva S PandaAdel S GirgisYosra I NagyRiham F GeorgeWalid FayadNehmedo G FawzyTarek S IbrahimAmany M M Al-MahmoudyRajeev SakhujaZakaria K M Abdel-SamiiPublished in: Chemical biology & drug design (2019)
A series of new fluoroquinolone conjugates 8a-g and 9a-f were synthesized via benzotriazole-mediated synthetic approach with good yield and purity. Some of the synthesized analogs exhibited significant antibacterial properties against Escherichia coli and Staphylococcus aureus with potency higher than that of the parent drugs through in vitro standard bioassay procedure (conjugates 8c and 8d reveal antimicrobial properties with potency 1.9, 61.9, 20.7 and 2.4, 37.1, 8.3 folds relative to the parent antibiotic 6 against E. coli, S. aureus, and Enterococcus faecalis, respectively). The observed experimental data were supported by enzymatic DNA gyrase inhibitory property. Developed BMLR-QSAR model validates the observed experimental data and recognizes the parameters responsible for the enhanced antibacterial properties.
Keyphrases
- staphylococcus aureus
- escherichia coli
- electronic health record
- circulating tumor
- molecular docking
- cell free
- single molecule
- big data
- biofilm formation
- hydrogen peroxide
- cancer therapy
- silver nanoparticles
- genome wide
- klebsiella pneumoniae
- drug delivery
- methicillin resistant staphylococcus aureus
- artificial intelligence
- cystic fibrosis